Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Selective Release of Calpain Produced αII-Spectrin (α-Fodrin) Breakdown Products by Acute Neuronal Cell Death

Satavisha Dutta / Yuk Chun Chiu / Albert W. Probert / Kevin K.W. Wang

Citation Information: Biological Chemistry. Volume 383, Issue 5, Pages 785–791, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2002.082, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Activation of calpain results in the breakdown of α II spectrin (αfodrin), a neuronal cytoskeleton protein, which has previously been detected in various in vitro and in vivo neuronal injury models. In this study, a 150 kDa spectrin breakdown product (SBDP150) was found to be released into the cellconditioned media from SHSY5Y cells treated with the calcium channel opener maitotoxin (MTX). SBDP150 release can be readily quantified on immunoblot using an SBDP150- specific polyclonal antibody. Increase of SBDP150 also correlated with cell death in a timedependent manner. MDL28170, a selective calpain inhibitor, was the only protease inhibitor tested that significantly reduced MTXinduced SBDP150 release. The cellconditioned media of cerebellar granule neurons challenged with excitotoxins (NMDA and kainate) also exhibited a significant increase of SBDP150 that was attenuated by pretreatment with an NMDA receptor antagonist, R()-3-(2-carbopiperazine-4-yl)propyl-1- phosphonic acid (CPP), and MDL28170. In addition, hypoxic/hypoglycemic challenge of cerebrocortical cultures also resulted in SBDP150 liberation into the media. These results support the theory that an antibody based detection of SBDP150 in the cellconditioned media can be utilized to quantify injury to neural cells. Furthermore, SBDP150 may potentially be used as a surrogate biomarker for acute neuronal injury in clinical settings.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Linda Papa, Claudia S. Robertson, Kevin K. W. Wang, Gretchen M. Brophy, H. Julia Hannay, Shelley Heaton, Ilona Schmalfuss, Andrea Gabrielli, Ronald L. Hayes, and Steven A. Robicsek
Neurocritical Care, 2015, Volume 22, Number 1, Page 52
[2]
Marian S. Chin, Laura C. Hooper, John J. Hooks, and Barbara Detrick
Journal of Neuroimmunology, 2014, Volume 272, Number 1-2, Page 42
[3]
Charmaine M. Tate, Kevin K.W. Wang, Stephanie Eonta, Yang Zhang, Walter Carr, Frank C. Tortella, Ronald L. Hayes, and Gary H. Kamimori
Journal of Neurotrauma, 2013, Volume 30, Number 19, Page 1620
[4]
J. Susie Zoltewicz, Stefania Mondello, Boxuan Yang, Kimberly J. Newsom, Firas Kobeissy, Changping Yao, Xi-Chun May Lu, Jitendra R. Dave, Deborah A. Shear, Kara Schmid, Virginia Rivera, Terri Cram, Jixiang Seaney, Zhiqun Zhang, Kevin K.W. Wang, Ronald L. Hayes, and Frank C. Tortella
Journal of Neurotrauma, 2013, Volume 30, Number 13, Page 1161
[5]
Joy D. Guingab-Cagmat, Kimberly Newsom, Anatoliy Vakulenko, Emilio B. Cagmat, Firas H. Kobeissy, Susie Zoltewicz, Kevin K. Wang, and John Anagli
ELECTROPHORESIS, 2012, Volume 33, Number 24, Page 3786
[6]
Jie Li, Catherine Kil, Kelly Considine, Bartosz Smarkucki, Michael C Stankewich, Brian Balgley, and Alexander O Vortmeyer
Laboratory Investigation, 2013, Volume 93, Number 2, Page 242
[7]
Raquel Hernández, Santos Blanco, Juan Peragón, Juan Á. Pedrosa, and María Á. Peinado
NeuroMolecular Medicine, 2013, Volume 15, Number 1, Page 82
[8]
Wen-Ching Lee, Yun-Yu Chen, Daphne Kan, and Chung-Liang Chien
Journal of Biomedical Science, 2012, Volume 19, Number 1, Page 8
[9]
Minghui Jessica Chen, Yann Wan Yap, Meng Shyan Choy, Chor Hui Vivien Koh, Sze Jee Seet, Wei Duan, Matthew Whiteman, and Nam Sang Cheung
Neuroscience Letters, 2006, Volume 397, Number 1-2, Page 69
[10]
A. Raquel Esteves, Daniela M. Arduíno, Russell H. Swerdlow, Catarina R. Oliveira, and Sandra M. Cardoso
Neurobiology of Disease, 2010, Volume 37, Number 3, Page 723
[11]
Eric S. Weiss, Kevin K.W. Wang, Jeremiah G. Allen, Mary E. Blue, Lois U. Nwakanma, Ming Cheng Liu, Mary S. Lange, Jennifer Berrong, Mary Ann Wilson, Vincent L. Gott, Juan C. Troncoso, Ronald L. Hayes, Michael V. Johnston, and William A. Baumgartner
The Annals of Thoracic Surgery, 2009, Volume 88, Number 2, Page 543
[12]
In Koo Hwang, Ki-Yeon Yoo, Dae Won Kim, Hua Li, Ok Kyu Park, Choong Hyun Lee, Jung Hoon Choi, and Moo-Ho Won
Neuroscience Letters, 2008, Volume 435, Number 3, Page 251
[13]
Matthew W. Warren, Firas H. Kobeissy, Ming Cheng Liu, Ronald L. Hayes, Mark S. Gold, and Kevin K.W. Wang
Life Sciences, 2005, Volume 78, Number 3, Page 301
[14]
Lucy M. Elphick, Mohammad Hawat, Nick J. Toms, Annika Meinander, Andrey Mikhailov, John E. Eriksson, and George E.N. Kass
Toxicology and Applied Pharmacology, 2008, Volume 232, Number 2, Page 258
[15]
Fransisca Indraswari, Peter T.H. Wong, Elgin Yap, Y.K. Ng, and S. Thameem Dheen
Neurochemistry International, 2009, Volume 55, Number 4, Page 235
[16]
Toshiaki Maruyama, Ichiro Saito, Yoshio Hayashi, Elizabeth Kompfner, Robert I. Fox, Dennis R. Burton, and Henrik J. Ditzel
The American Journal of Pathology, 2004, Volume 165, Number 1, Page 53
[17]
Robert Siman, Tracy K McIntosh, Kristie M Soltesz, Zhaoming Chen, Robert W Neumar, and Victoria L Roberts
Neurobiology of Disease, 2004, Volume 16, Number 2, Page 311
[18]
Zhiqun Zhang, Andrew K Ottens, Shankar Sadasivan, Firas H. Kobeissy, Tie Fang, Ronald L. Hayes, and Kevin K.W. Wang
Journal of Neurotrauma, 2007, Volume 24, Number 3, Page 460
[19]
Beate Jaekel, Katja Mühlberg, Susana Garcia de Arriba, Andreas Reichenbach, Ester Verdaguer, Mercè Pallas, Antoni Camins, Wolfgang Nörenberg, and Clemens Allgaier
British Journal of Pharmacology, 2009, Volume 147, Number 6, Page 622
[20]
Zhiqun Zhang, Stephen F. Larner, Ming Cheng Liu, Wenrong Zheng, Ronald L. Hayes, and Kevin K. W. Wang
Apoptosis, 2009, Volume 14, Number 11, Page 1289
[21]
Seth T. Gammon, Victor M. Villalobos, Mikhail Roshal, Mustapha Samrakandi, and David Piwnica-Worms
Biotechnology Progress, 2009, Volume 25, Number 2, Page 559
[22]
Kohji Fukunaga, Feng Han, Norifumi Shioda, Shigeki Moriguchi, Jiro Kasahara, and Yasufumi Shirasaki
Cardiovascular Drug Reviews, 2006, Volume 24, Number 2, Page 88
[23]
Yann Wan Yap, Matthew Whiteman, Boon Huat Bay, Yuhong Li, Fwu-Shan Sheu, Robert Z. Qi, Chee Hong Tan, and Nam Sang Cheung
Journal of Neurochemistry, 2006, Volume 98, Number 5, Page 1597
[24]
Ming Cheng Liu, Veronica Akle, Wenrong Zheng, Jason Kitlen, Barbara O'Steen, Stephen F. Larner, Jitendra R. Dave, Frank C. Tortella, Ronald L. Hayes, and Kevin K. W. Wang
Journal of Neurochemistry, 2006, Volume 98, Number 3, Page 700
[25]
Miwa Takamure, Ken-Ya Murata, Yoshiyuki Tamada, Mitsuyoshi Azuma, and Satoshi Ueno
Muscle & Nerve, 2005, Volume 32, Number 3, Page 303
[26]
Jocelyn C. Leung, Tara Marphis, Randall D. Craver, and Douglas M. Silverstein
Kidney International, 2004, Volume 66, Number 1, Page 167

Comments (0)

Please log in or register to comment.